Ben Adeyi

2.7k citations

29 papers · 680 indexed · h-index 17

Impact in

Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
Applied Microbiology and Biotechnology top 5%

Papers in ⓘ

Psychiatry and Mental health 24
- Attention Deficit Hyperactivity Disorder 24
- Bipolar Disorder and Treatment 10
Cognitive Neuroscience 16
- Autism Spectrum Disorder Research 8
- Functional Brain Connectivity Studies 8
- Neural and Behavioral Psychology Studies 4

Co-authors: Bryan Dirks (14 shared papers)T. Babcock (14 shared papers)Robert Lasser (10 shared papers)Gail L. Woods (3 shared papers)David Coghill (8 shared papers)Hedy Teppler (2 shared papers)Alessandro Zuddas (5 shared papers)Paul Hodgkins (5 shared papers)
Journals: Journal of Attention Disorders (4 papers)CNS Drugs (4 papers)Journal of Child and Adolescent Psychopharmacology (3 papers)European Child & Adolescent Psychiatry (3 papers)Child and Adolescent Psychiatry and Mental Health (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Ben Adeyi

29 papers receiving 647 citations

Peers

Countries citing papers authored by Ben Adeyi

Since Specialization

Citations

This map shows the geographic impact of Ben Adeyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Adeyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Adeyi more than expected).

Fields of papers citing papers by Ben Adeyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Adeyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Adeyi. The network helps show where Ben Adeyi may publish in the future.

Co-authors

The 25 scholars most cited alongside Ben Adeyi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Adeyi Line = papers co-authored together Ben Adeyi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy, Immunogenicity, and Safety of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine at the End of Shelf Life PEDIATRICS ·Stan L. Block, Timo Vesikari, Michelle G. Goveia, Stephen B. Rivers, Ben Adeyi, Michael J. Dallas, Jeffrey Bauder, John W. Boslego, Penny M. Heaton, (unknown)	2007	108
2	Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults International Journal of Antimicrobial Agents ·Albert E. Yellin, James M. Hassett, Álvaro Fernández-Quilez, James Geib, Ben Adeyi, Gail L. Woods, Hedy Teppler	2002	56
3	Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder CNS Drugs ·Tobias Banaschewski, César A. Soutullo, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Paul Hodgkins, Ben Adeyi, Liza Squires, David Coghill	2013	51
4	Ertapenem Once a Day Versus Piperacillin–Tazobactam Every6 Hours for Treatment of Acute Pelvic Infections:A Prospective, Multicenter, Randomized, Double‐Blind Study Infectious Diseases in Obstetrics and Gynecology ·Subir Roy, Iliana Higareda, Edith Ángel‐Müller, Mahmoud Ismail, Caren Hague, Ben Adeyi, Gail L. Woods, Hedy Teppler	2002	49
5	Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit European Journal of Clinical Microbiology & Infectious Diseases ·S. V. Yakovlev, L. Stratchounski, Gail L. Woods, Ben Adeyi, K. A. McCarroll, Joy Ginanni, Ian R. Friedland, C A Wood, Mark J. DiNubile	2006	41
6	Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder CNS Drugs ·Tobias Banaschewski, Mats Johnson, Michel Lecendreux, Alessandro Zuddas, Ben Adeyi, Paul Hodgkins, Liza Squires, David Coghill	2014	36
7	Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder CNS Drugs ·James Ermer, Ben Adeyi, Michael L. Pucci	2010	32
8	Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder BMC Psychiatry ·Gregory W. Mattingly, Richard H. Weisler, Joel Young, Ben Adeyi, Bryan Dirks, T. Babcock, Robert Lasser, Brian Scheckner, D. Wayne Goodman	2013	30
9	The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial Journal of Attention Disorders ·Ann Childress, Valerie Arnold, Ben Adeyi, Bryan Dirks, T. Babcock, Brian Scheckner, Robert Lasser, Frank A. López	2012	29
10	Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder CNS Drugs ·Regina Dittmann, Esther Cardo, Péter Nagy, Colleen Anderson, Ben Adeyi, Beatriz Caballero, Paul Hodgkins, Richard Civil, David Coghill	2014	27
11	Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis Child and Adolescent Psychiatry and Mental Health ·Rakesh K. Jain, T. Babcock, Teodor Burtea, Bryan Dirks, Ben Adeyi, Brian Scheckner, Robert Lasser	2011	23
12	Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day Child and Adolescent Psychiatry and Mental Health ·Sharon B. Wigal, Scott H. Kollins, Ann Childress, Ben Adeyi	2010	22
13	Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study Journal of Child and Adolescent Psychopharmacology ·Atilla Turgay, Lawrence Ginsberg, Elias Sarkis, Rakesh K. Jain, Ben Adeyi, Joseph Gao, Bryan Dirks, T. Babcock, Brian Scheckner, Cynthia Richards, Robert Lasser, Robert L. Findling	2010	21
14	Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate European Child & Adolescent Psychiatry ·Péter Nagy, Alexander Häge, David Coghill, Beatriz Caballero, Ben Adeyi, Colleen Anderson, Vanja Sikirica, Esther Cardo	2015	20
15	Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults Current Medical Research and Opinion ·Thomas E. Brown, Matthew Brams, Maria Gasior, Ben Adeyi, T. Babcock, Bryan Dirks, Brian Scheckner, Timothy Wigal	2011	20
16	Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity Current Medical Research and Opinion ·Lawrence Ginsberg, Alain Katic, Ben Adeyi, Bryan Dirks, T. Babcock, Robert Lasser, Brian Scheckner, Lenard A. Adler	2011	20
17	Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial Neuropsychiatric Disease and Treatment ·Katharine Murkett, Tobias Banaschewski, Michel Lecendreux, César A. Soutullo, Alessandro Zuddas, Ben Adeyi, Shaw Sorooshian, David Coghill	2014	18
18	Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study Journal of Attention Disorders ·Richard H. Weisler, Lawrence Ginsberg, Bryan Dirks, Patrick Deas, Ben Adeyi, Lenard A. Adler	2014	14
19	Clinical Response and Symptomatic Remission in Children Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder CNS Spectrums ·Robert L. Findling, Ben Adeyi, Gary Chen, Bryan Dirks, T. Babcock, Brian Scheckner, Robert Lasser, Michael L. Pucci, Huda Ismail Abdullah, James J. McGough	2010	10
20	Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate Journal of Attention Disorders ·Alain Katic, Lawrence Ginsberg, Rakesh K. Jain, Ben Adeyi, Bryan Dirks, T. Babcock, Brian Scheckner, Cynthia Richards, Robert Lasser, Atilla Turgay, Robert L. Findling	2010	10

About Ben Adeyi

Ben Adeyi is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience, Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 29 papers that have together received 680 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (24 papers), Bipolar Disorder and Treatment (10 papers), Autism Spectrum Disorder Research (8 papers), Functional Brain Connectivity Studies (8 papers), Neural and Behavioral Psychology Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Children's Physical and Motor Development (3 papers) and Treatment of Major Depression (3 papers). The work is most often cited by research in Psychiatry and Mental health (414 citations), Applied Microbiology and Biotechnology (46 citations), Cognitive Neuroscience (211 citations), Molecular Medicine (53 citations) and Hepatology (58 citations). Ben Adeyi has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Bryan Dirks, T. Babcock, Robert Lasser, Gail L. Woods, David Coghill, Hedy Teppler, Alessandro Zuddas, Paul Hodgkins, Michel Lecendreux and Tobias Banaschewski. Their work appears in journals such as Journal of Attention Disorders, CNS Drugs, Journal of Child and Adolescent Psychopharmacology, European Child & Adolescent Psychiatry and Child and Adolescent Psychiatry and Mental Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact